60 Degrees PharmaSXTP
13F holders, Q1 2026 (March 31)8holders
$1.75avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding 60 Degrees Pharma Inc. (SXTP) in their 13F filings. The largest holders were Kathmere Capital Management, LLC ($253K), UBS Group AG ($55K) and Geode Capital Management, LLC ($29K).
- Company
- 60 Degrees Pharma Inc.
- CUSIP
- 83006G500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $340K |
| Exits | 0 | $0 |
Ownership 8 holders
| Kathmere Capital Management, LLC | 0.02% | New | 144,683 | $253K |
| UBS Group AG | 0.00% | New | 31,410 | $55K |
| Geode Capital Management, LLC | 0.00% | New | 16,295 | $29K |
| Barclays PLC | 0.00% | New | 1,856 | $3K |
| NewEdge Advisors, LLC | 0.00% | New | 50 | $88 |
| Osaic Holdings, Inc. | 0.00% | New | 25 | $43 |
| Twin Peaks Wealth Advisors, LLC | 0.00% | New | 8 | $14 |
| Citigroup Inc. | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is SXTP's weight in each manager's 13F, not the share of 60 Degrees Pharma Inc. the manager owns.